Back to Previous Page
New SearchHide Search
Erenumab has been studied in several large, global, randomized, double-blind, placebo-controlled studies to assess its safety and efficancy in migraine prevention.
This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.
This file is for journalists only. Please fill out the form below to request access.
By submitting this field I verify that I am a journalist.
You are here
This site is intended for a global audience.